Literature DB >> 31603598

Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014.

M Ørbaek1,2, K Thorsteinsson1, E Moseholm Larsen1, T L Katzenstein2,3, M Storgaard4, I S Johansen5, G Pedersen6, D Bach7, M Helleberg2, N Weis1,3, A-M Lebech2,3.   

Abstract

OBJECTIVES: We aimed to compare risk factors for adverse pregnancy outcomes in women living with HIV (WLWH) with those in women of the general population (WGP) in Denmark. Further, we estimated risk of pregnancy- or birth-related complications.
METHODS: A retrospective cohort study including all WLWH who delivered a live-born child from 2002 to 2014 and WGP, matched by origin, age, year and parity, was carried out. We compared risk factors during pregnancy and estimated risk of pregnancy- and birth-related complications using multivariate logistic regression.
RESULTS: A total of 2334 pregnancies in 304 WLWH and 1945 WGP were included in the study. WLWH had more risk factors present than WGP during pregnancy: previous caesarean section (CS) (24.7% versus 16.3%, respectively; P = 0.0001), smoking (14.2% versus 7.5%, respectively; P = 0.0001) and previous perinatal/neonatal death (2.3% versus 0.9%, respectively; P = 0.03). We found no difference between groups regarding gestational diabetes, hypertensive disorders, low birth weights or premature delivery. More children of WLWH had intrauterine growth retardation (IUGR) [adjusted odds ratio (aOR) 1.9; 95% confidence interval (CI) 1.1-3.2; P = 0.02]. Median gestational age and birth weight were lower in children born to WLWH. WLWH had a higher risk of emergency CS (EmCS) (aOR 1.6; 95% CI 1.2-2.1; P = 0.0005) and postpartum haemorrhage (aOR 1.4; 95% CI 1.0-1.9; P = 0.02) but not infection, amniotomy, failure to progress, low activity-pulse-grimace-appearance-respiration (APGAR) score or signs of asphyxia.
CONCLUSIONS: WLWH had more risk factors present during pregnancy, similar risks of most pregnancy- and birth-related complications but a higher risk of postpartum haemorrhage and EmCS compared with WGP. Children born to WLWH had lower median birth weights and gestational ages and were at higher risk of IUGR.
© 2019 British HIV Association.

Entities:  

Keywords:  birth complications; caesarean section; intrauterine growth retardation; pregnancy; preterm delivery; risk factors; women living with HIV

Mesh:

Year:  2019        PMID: 31603598     DOI: 10.1111/hiv.12798

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  4 in total

1.  Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohort.

Authors:  Kartik K Venkatesh; Andrew Edmonds; Daniel Westreich; Jodie Dionne-Odom; Deborah Jones Weiss; Anandi N Sheth; Helen Cejtin; Dominika Seidman; Seble Kassaye; Howard Minkoff; Jessica Atrio; Lisa Rahangdale; Adaora A Adimora
Journal:  HIV Med       Date:  2021-09-12       Impact factor: 3.094

2.  Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.

Authors:  Andrew Edmonds; Ellen Brazier; Beverly S Musick; Marcel Yotebieng; John Humphrey; Lisa L Abuogi; Adebola Adedimeji; Olivia Keiser; Malango Msukwa; James G Carlucci; Marcelle Maia; Jorge A Pinto; Valériane Leroy; Mary-Ann Davies; Kara K Wools-Kaloustian
Journal:  PLoS Med       Date:  2022-09-15       Impact factor: 11.613

3.  Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population-based cohort study.

Authors:  Ellen Moseholm; Terese Lea Katzenstein; Gitte Pedersen; Isik Somuncu Johansen; Lisa Skyggelund Wienecke; Merete Storgaard; Niels Obel; Nina Weis
Journal:  HIV Med       Date:  2022-04-06       Impact factor: 3.094

4.  The Danish HIV Birth Cohort (DHBC) - a nationwide, prospective cohort.

Authors:  Nina Weis; Terese L Katzenstein; Mathilde Ørbæk; Merete Storgaard; Gitte Pedersen; Isik S Johansen; Ellen Moseholm
Journal:  BMJ Open       Date:  2021-07-08       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.